Role of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis

Cellular and Molecular Life Sciences

Volumn 68, Issue 19, 2011, Pages 3249-3260

  Moon, Dong Oh ^a   Choi, Yung Hyun ^b   Kim, Gi Young ^a  

^a Jeju National University   (South Korea)

^b Dong Eui University   (South Korea)

Author keywords

Apoptosis; Endoreduplication; G2 M phase; P21; SP600125

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN E; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P21; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; ENDOREDUPLICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ANTHRACENES; APOPTOSIS; CELL CYCLE; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G2 PHASE; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; U937 CELLS;

EID: 80052923735     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0626-5     Document Type: Article

References (39)

1. Du L, Lyle CS, Obey TB, Gaarde WA, Bennett BL, Chambers TC (2000) Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent. J Biol Chem 279:11957-11966 (Pubitemid 38401701)
2. Hideshima T, Hayashi T, Chauhan D, Akiyama M, Richardson P, Anderson K (2003) Biologic sequelae of c-Jun NH2-terminal kinase (JNK) activation in multiple myeloma cell lines. Oncogene 22:8797-8801 (Pubitemid 38010503)
3. Jacobs-Helber SM, Sawyer ST (2004) Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin- dependent cell lines. Blood 104:696-703 (Pubitemid 38970562)
4. Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL (2004) Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 23:596-604 (Pubitemid 38175015)
5. Wang Q, Wieder R (2004) All-trans retinoic acid potentiates taxotere-induced cell death mediated by Jun-N-terminal kinase in breast cancer cells. Oncogene 23:426-433 (Pubitemid 38174997)
6. Kuntzen C, Sonuc N, De Toni EN, Opelz C, Mucha SR, Gerbes AL, Eichhorst ST (2005) Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/ M cell cycle arrest. Cancer Res 65:6780-6788 (Pubitemid 41060716)
7. Taylor WR, Schonthal AH, Galante J, Stark GR (2001) Regulation of the G2/M transition by p53. J Biol Chem 276:1998-2006
8. Rozan LM, El-Deiry WS (2007) p53 downstream target genes and tumor suppression: a classical view in evolution. Cell Death Differ 14:3-9 (Pubitemid 44911889)
9. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev 9:1149-1163
10. Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578 (Pubitemid 24192528)
11. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027
12. Esposito F, Cuccovillo F, Vanoni M, Cimino F, Anderson CW, Appella E, Russo T (1997) Redox-mediated regulation of p21waf1/ cip1 expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway. Eur J Biochem 245:730-737 (Pubitemid 27223907)
13. Akashi M, Osawa Y, Koeffler HP, Hachiya M (1999) p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization. Biochem J 337:607-616
14. Gartel AL, Tyner AL (1999) Transcriptional regulation of the p21(WAF1/CIP1) gene. Exp Cell Res 246:280-289
15. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825 (Pubitemid 23346378)
16. Rössig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM, Dimmeler S (2001) Akt-dependent phosphorylation of p21Cip1 regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol 21:5644-5657 (Pubitemid 32702467)
17. Li Y, Dowbenko D, Lasky LA (2002) AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277:11352-11361 (Pubitemid 34952901)
18. Hwang-Verslues WW, Sladek FM (2008) Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 22:78-90
19. Datto MB, Yu Y, Wang XF (1995) Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270:28623-28628
20. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ (1998) Increasing complexity of Ras signaling. Oncogene 17:1395-1413 (Pubitemid 28458409)
21. Moreno S, Hayles J, Nurse P (1989) Regulation of p34cdc2 protein kinase during mitosis. Cell 58:361-372 (Pubitemid 19191417)
22. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3:245-252 (Pubitemid 32201319)
23. Leslie NR, Downes CP (2004) PTEN function: how normal cells control it and tumour cells lose it. Biochem J 382:1-11 (Pubitemid 39141560)
24. Tsurimoto T (1998) PCNA, a multifunctional ring on DNA. Biochim Biophys Acta 1443:23-39 (Pubitemid 29016008)
25. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S (1999) Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation. EMBO J 18:1223-1234 (Pubitemid 29110307)
26. Coqueret O (2003) New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 13:65-70 (Pubitemid 36135887)
27. Harms C, Albrecht K, Harms U, Seidel K, Hauck L, Baldinger T, Hübner D, Kronenberg G, An J, Ruscher K, Meisel A, Dirnagl U, von Harsdorf R, Endres M, Hörtnagl H (2007) Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21Waf1/Cip1 as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci 27:4562-4571 (Pubitemid 46663587)
28. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252
29. Lin A (2003) Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25:17-24 (Pubitemid 36093321)
30. Xiong Y, Zhang H, Beach D (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7:1572-1583 (Pubitemid 23234350)
31. Aikin R, Maysinger D, Rosenberg L (2004) Cross-talk phosphatidylinositol 3-kinase/AKT and c-Jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology 145:4522-4531 (Pubitemid 39281444)
32. Allen RT, Krueger KD, Dhume A, Agrawal DK (2005) Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis 10:525-535 (Pubitemid 40896659)
33. Fornoni A, Pileggi A, Molano RD, Sanabria NY, Tejada T, Gonzalez-Quintana J, Ichii H, Inverardi L, Ricordi C, Pastori RL (2008) Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51:298-308
34. Moon DO, Kim MO, Choi YH, Kim ND, Chang JH, Kim GY (2008) Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells. Cancer Lett 264:316-325
35. Suzuki A, Tsutomi Y, Yamamoto N, Shibutani T, Akahane K (1999) Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist fasmediated cell death. Mol Cell Biol 19:3842-3847 (Pubitemid 29193843)
36. Xu SQ, El-Deiry WS (2000) p21WAF1/CIP1 inhibits initiator caspase cleavage by TRAIL death receptor DR4. Biochem Biophys Res Commun 269:179-190 (Pubitemid 30440274)
37. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S (1999) Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. EMBO J 18:1223-1234 (Pubitemid 29110307)
38. Liang J, Slingerland JM (2003) Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2:339-345
39. Maddika S, Ande SR, Wiechec E, Hansen LL, Wesselborg S, Los M (2008) Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis. J Cell Sci 121:979-988 (Pubitemid 351639417)